• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VALEANT PHARMACEUTICALS INTERNATIONAL BIAFINE TOPICAL EMULSION; DRESSING,WOUND & BURN,HYDROGEL W/DRUG &/OR BIOLOGI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VALEANT PHARMACEUTICALS INTERNATIONAL BIAFINE TOPICAL EMULSION; DRESSING,WOUND & BURN,HYDROGEL W/DRUG &/OR BIOLOGI Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Gangrene (1873); Unspecified Infection (1930); Deformity/ Disfigurement (2360); Post Traumatic Wound Infection (2447)
Event Date 12/01/2015
Event Type  Injury  
Manufacturer Narrative
The product was not returned and the lot number was not reported.The consumer reported the product was prescribed for an existing infection and that he did not develop an infection from the product.Based on all information, no causal factors can be determined and no conclusion can be drawn.
 
Event Description
It was reported a patient used the product as treatment by applying it to his middle toe once daily and covered for 24 hours.The patient developed an unspecified infection four days after starting the product.The patient was hospitalized and treated with unspecified iv antibiotics.Six days later while in the hospital, the patient developed gangrene and his middle toe was amputated.The patient was discharged four days later with unspecified iv antibiotics.The patient's wound has healed.Upon follow-up with the patient, he reported the product was prescribed for an existing infection and that he did not develop an infection from the product.Medical documentation has been requested but not received.
 
Manufacturer Narrative
Follow-up report submitted to provide correct information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIAFINE TOPICAL EMULSION
Type of Device
DRESSING,WOUND & BURN,HYDROGEL W/DRUG &/OR BIOLOGI
Manufacturer (Section D)
VALEANT PHARMACEUTICALS INTERNATIONAL
rochester NY 14609
Manufacturer (Section G)
JOHNSON & JOHNSON FRANCE VAL DE REUIL
campus de maigremont bp615
27106 val de reuil cedex
france
FR  
Manufacturer Contact
sharon spencer
50 technology drive west
irvine, CA 92618
9493985698
MDR Report Key5461846
MDR Text Key39086051
Report Number3009443653-2016-00003
Device Sequence Number1
Product Code MGQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K964240
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/01/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention; Disability;
Patient Age55 YR
-
-